ArticleDigestive diseases and sciences2025
Evaluation of a Predictive Model and Clinical Outcomes in Mild Acute Pancreatitis: Towards Evidence-Based Early Discharge.
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiven that the care for mild acute pancreatitis (AP) patients is often supportive, these patients may, due to the current strain on hospital care, be eligible for early hospital discharge. However, timely identification of this population and information about their clinical course is needed. This study aims to identify a reliable method for predicting a mild course at 24 and 48 h after hospitalization and to assess clinical outcomes to optimize future early discharge strategies.
methodsThis retrospective cohort study included consecutive AP patients admitted to a large teaching hospital in the Netherlands from January 2014 to September 2024, with 90-days follow-up. AP course was predicted using four methods involving C-reactive Protein (CRP) and Systemic Inflammatory Response Syndrome (SIRS). Clinical outcomes, including readmissions, were reported.
resultsA total of 1313 patients were included, of whom 1154 (87.9%) had a confirmed mild course. Of these, 12.9% had AP-related readmissions and 1.8% died within 90 days. For the four prediction methods, positive predictive values ranged from 92.1 to 96.5%, and sensitivity from 51.1 to 79.4%. For predicted mild AP patients, readmission rates ranged from 14.0 to 15.2%, and mortality rates from 1.6 to 2.2%. Recurrent or ongoing AP was the main cause of readmission.
conclusionsThis study found that readmissions are common in mild AP patients, mainly due to recurrent or ongoing AP. CRP and SIRS are suitable in predicting a mild course, potentially within 24 h of admission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.